Trials / Conditions / Somatostatin-Producing Neuroendocrine Tumor
Somatostatin-Producing Neuroendocrine Tumor
3 registered clinical trials studyying Somatostatin-Producing Neuroendocrine Tumor.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine NCT02831179 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Completed | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade N NCT01204476 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer NCT00454363 | National Cancer Institute (NCI) | Phase 2 |